Naphthalene

Naphthalene

SCHEMBL4357918

CN.c1ccc2ccccc2c1

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 9/20 0.73
ALOX12 P18054 1/20 0.73
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 3/20 0.47
CYP3A4 P08684 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
TSHR P16473 3/20 0.44
CYP1A2 P05177 4/20 0.43
HTR2A P28223 2/20 0.41
ALOX15 P16050 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HPGD P15428 1/20 0.40
KEAP1 Q14145 1/20 0.40
ACHE P22303 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthalene SCHEMBL3058088 0.86 CYP2A6 (0.80) CYP2A6ALOX12ALDH1A1HSD17B10CYP3A4
Naphthalene SCHEMBL1451946 0.86 CYP2A6 (0.80) CYP2A6ALOX12ALDH1A1HSD17B10CYP3A4
Naphthalene SCHEMBL29358073 0.85 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10CYP3A4
Naphthalene SCHEMBL8613802 0.85 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10CYP3A4
Naphthalene SCHEMBL30685720 0.85 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10CYP3A4
Naphthalene SCHEMBL8953 0.85 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10CYP3A4
Naphthalene SCHEMBL1332240 0.85 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10CYP3A4
Naphthalene SCHEMBL1331142 0.85 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10CYP3A4
Naphthalene SCHEMBL1330659 0.85 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10CYP3A4
Naphthalene SCHEMBL1293896 0.85 CYP2A6 (1.00) CYP2A6ALOX12ALDH1A1HSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116284692-B High-Tg hydrocarbon resin, resin composition for high-frequency copper-clad plate and preparation method and application thereof 四川东材科技集团股份有限公司 2025-02-07 CN claimed
CN-116284692-A high-Tg hydrocarbon resin, resin composition for high-frequency copper-clad plate and preparation method and application thereof 四川东材科技集团股份有限公司 2023-06-23 CN claimed
CN-110423200-A A kind of preparation method improving terbinafine HCl purity CHENGDU AOBANG MEDICINE CO LTD 2019-11-08 CN claimed
CN-108630820-A A kind of exchange plane organic electroluminescence device 北京大学深圳研究生院 2018-10-09 CN claimed
CN-106093159-B A kind of preparation method of the biosensor based on polypeptide-gold nanoparticle detection metal ion 大连理工大学 2018-06-08 CN claimed
CN-104130843-B A kind of spindle fluid composition 中国石油化工股份有限公司 2017-07-14 CN claimed
CN-101848921-A Novel Sugar Derivatives GLYCOM AS 2010-09-29 CN claimed
CN-101569864-A Chiral sulfonamide organic micromolecule catalyst and application thereof UNIV SUN YAT SEN (CN) 2009-11-04 CN claimed
CN-1114669-C Normal temp. solidified conveying band joint chloroprene rubber adhesive HUANG SHIDE (CN) 2003-07-16 CN claimed
EP-1282680-A1 COMPOSITIONS COMPRISING CYCLODEXTRIN THE PROCTER & GAMBLE COMPANY (US) 2003-02-12 EP claimed
US-6503413-B2 Polyalkylene polysiloxane, buffering agent, aqueous carrier THE PROCTER & GAMBLE COMPANY 2003-01-07 US claimed
EP-1255806-A1 STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS THE PROCTER & GAMBLE COMPANY (US) 2002-11-13 EP claimed
US-20020011584-A1 Stable, aqueous compositions for treating surfaces, especially fabrics THE PROCTOR & GAMBLE COMPANY 2002-01-31 US claimed
US-20020010154-A1 Compositions comprising cyclodextrin THE PROCTER & GAMBLE COMPANY 2002-01-24 US claimed
WO-2001088076-A1 COMPOSITIONS COMPRISING CYCLODEXTRIN THE PROCTER & GAMBLE COMPANY (US) 2001-11-22 WO claimed
WO-2001060961-A1 STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS THE PROCTER & GAMBLE COMPANY (US) 2001-08-23 WO claimed
CN-1272520-A Normal temp. solidified conveying band joint chloroprene rubber adhesive HUANG HONGXIA (CN) 2000-11-08 CN claimed
US-5427888-A Positive photosensitive resin composition comprising a polymer having carbon-carbon double bonds, a maleic acid group and a maleimide group NIPPON OIL CO., LTD. (JP) 1995-06-27 US claimed
EP-4688889-A1 ENAMINES AS INITIATORS IN THE CURING OF FREE-RADICALLY CURING REACTIVE RESINS FOR CHEMICAL FASTENING Hilti Aktiengesellschaft (LI) 2026-02-11 EP disclosed
US-4128497-A TRISAZO DYE GENERAL ELECTRIC COMPANY (US) 1978-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010154-A1 Compositions comprising cyclodextrin FFAR4, FRG1, FGB CYP2A6 1137/4885ALOX12 1548/4885ALDH1A1 3053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.